Reportlinker.com

Reportlinker.com

July 07, 2008 09:43 ET

Focus on the World Chiral Technology Market

LONDON, UNITED KINGDOM--(Marketwire - July 7, 2008) - Reportlinker.com announces that a new market research report related to the Microelectronics industry is available in its catalogue.

World Chiral Technology Market

http://www.reportlinker.com/p090558/World-Chiral-Technology-Market.html

This report analyzes the worldwide markets for Chiral Technology in US$ Million. Chiral Technology Enabling Products analyzed are Intermediates, Analytical, and Others. The specific end-use segments discussed are Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 40 companies including many key and niche players worldwide such as Albemarle Corporation, BASF AG, Cambrex Corp., Chiral Quest Inc., Dalco ChromTech AB, Daicel Chemical Industries Ltd., DSM Pharmaceutical Products, DowpharmaSM, Johnson Matthey PLC, Regis Technologies Inc., Shasun Chemicals and Drugs Limited, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


CHIRAL TECHNOLOGY MCP-1098 
A GLOBAL STRATEGIC BUSINESS REPORT 


CONTENTS 


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 
Study Reliability and Reporting Limitations I-1 
Disclaimers I-2 
Data Interpretation & Reporting Level I-2 
Quantitative Techniques & Analytics I-3 
Product Definitions and Scope of Study I-3 
Chiral Technology Enabling Products I-4 
Chiral Intermediates I-4 
Analytical Products I-4 
Other Products I-4 
Chiral Technology End-Use Products I-4 
Pharmaceuticals I-4 
Agrochemicals I-4 

II. EXECUTIVE SUMMARY 

1. Introduction II-1 
An Insight into Chiral Technology II-1 
Techniques Used for Achieving Single-Isomers II-1 
Table 1: World Chiral Technology Market (2002 & 2010): 
Percentage Breakdown of Revenues by Techniques- Traditional 
Methods, Asymmetric Methods, and Biological Methods (includes 
corresponding Graph/Chart) II-2 
Importance and Advancements II-2 

2. Global Market Overview II-4 
Outlook and Trends II-4 
Good Tidings for Chiral Technology II-4 
Market Drivers II-5 
Demand for Chiral-based Therapeutic Drugs Augments Growth II-5 
New Legislations Push Chiral Technology Demand II-5 
Key Trends II-6 
Organizations Extend Approaches II-6 
Companies' Association with Universities II-6 

3. Chiral Technology - An Overview II-7 
Definitions II-7 
Chiral Technology Enabling Products II-7 
Chiral Intermediates II-7 
Analytical Products II-7 
Other Products II-7 
Chiral Technology End-Use Markets II-7 
Pharmaceuticals II-7 
Agrochemicals II-8 
Description II-8 
Functioning of Chiral Molecules II-9 
Chiral Preparation Process II-9 
Traditional Methods II-9 
Biological Methods II-9 
Asymmetric Methods II-10 
Chiral Separation II-10 
Chromatography - The Widely Used Method for Separation II-10 
How it Works? II-11 
Chiral Mobile Phase Additive (CMPA) II-11 
Chiral Stationary Phase (CSP) II-11 
Chiral Recognition II-12 
Protein Chiral Stationary Phases II-12 
Carbohydrate Columns II-12 
Pirkle Columns II-12 
Crystallization II-12 
Solvent Extraction II-13 
Kinetic Resolution II-13 
Capillary Electrophoresis II-14 
Receptor Based Resolution II-14 
Miscellaneous Separative Techniques II-14 
Chiral Synthesis II-14 

4. Chiral Technology - Development vs. Acquisition II-16 
In-House Creation & Development II-16 
Acquisition of Technology II-16 
"Economics" of Chiral Technology II-17 

5. Chiral Analysis Products II-18 
Chiral Analytical Chromatography II-18 
Chiral Liquid Chromatography II-18 
Supercritical Fluid Chromatography - Substitute to LC for 
Enantiomer Separations II-18 
Chiral Gas Chromatography II-18 
Chiral Simulated Moving Bed Chromatography II-19 
Partition Chromatography II-19 
Adsorption Chromatography II-19 
Computer Assisted Resolution II-19 
Chiral Polarimetry II-20 
Other Chiral Analytical Techniques II-20 
Calorimetry II-20 
Differential Scanning Calorimetry (DSC) II-20 
Enzymatic Assay II-20 
Immunoassay II-21 
Isotope Dilution II-21 
Nuclear Magnetic Resonance (NMR) II-21 
X-Ray Crystallography II-21 

6. Application Markets II-22 
Pharmaceuticals - The Largest Market II-22 
Changing Face of the Pharmaceutical Industry II-22 
Analysis of Chiral Drugs II-22 
Select Companies Involved in Chiral Technology Market II-23 
Table 2: Single-Enantiomer Drugs Market Worldwide (2006): 
Sales of Select Leading Brands (In US$ Billion) (includes 
corresponding Graph/Chart) II-23 
Drugs Built on Chiral Technology II-24 
Analgesics II-24 
Anesthetics II-24 
Anti-Infective Products II-24 
Cardiovascular System (CVS) Products II-25 
Angiotensin-Converting Enzyme (ACE) Inhibitors II-25 
Beta-Blockers II-25 
Calcium Channel Blockers II-25 
Diuretics II-25 
Vasodilators II-25 
Central Nervous System (CNS) Agents II-25 
Anticonvulsants II-25 
Sedatives and Tranquilizers II-26 
Stimulants and Antidepressants II-26 
Oncogenic (Cancer-Treatment) Products II-26 
Biochemicals II-26 
Oligonucleotides II-26 
Oxyacids II-27 
Amino Acids II-27 
Sugars and Other Oligosaccharides II-27 
Vitamins II-28 
Peptides II-28 
Pesticides - A Thriving Market II-29 
Herbicides II-29 
Insecticides II-29 
Fungicides II-30 
Other Products II-30 
Liquid Crystals II-30 
Flavor and Aroma Chemicals II-31 

7. Chiral Isomerism II-32 
Organic Chemical Isomerism Types II-32 
Structural Isomerism II-32 
Chain Isomerism II-32 
Position Isomerism II-32 
Functional Group Isomerism II-32 
Stereoisomerism II-32 
Dynamic Isomerism (Tautomerism) II-33 
Patents II-33 

8. Regulatory & Environmental Issues II-34 

9. Product Introductions II-35 
Degussa Develops Novel Processes to Synthesize (S) CAP II-35 
Regis Technologies, Inc. Launches RegisPack Chiral II-35 
Columns II-35 
Sigma-Aldrich Introduces ChiroSolv(TM) Kits II-35 
Sigma-Aldrich Launches Ascentis Express HPLC Columns II-35 
Evolved Nanomaterial Releases Revolutionary Analytical Chiral 
Column II-36 
BASF Develops Novel Process to Produce Chiral Intermediates II-36 
Chiral Quest Launches C3 TunePhos II-36 

10. Recent Industry Activity II-37 
Cambrex to Buy ProSyntest AS II-37 
Johnson Matthey and X-Zyme Sign Licensing Agreement II-37 
Chiral Quest Starts a New Production Facility II-37 
Chiral Quest Completes Reverse Merger with Surg II II-37 
DSM and IEP Extend Partnership II-37 
Shasun Chemicals Acquires Rhodia Pharma Solutions II-38 
Sigma-Aldrich Corp Acquires Astec II-38 
Solvias Receives License for MeOBIPHEP Catalyst Technology II-38 
Codexis Acquires Juelich Fine Chemicals II-38 
ChiroBlock Exits from Chiral Compounds Business II-38 
Chiral Quest Opens New Facility in China II-38 
Chiral Quest to Supply C3 TunePhos to Phoenix Chemicals II-38 
Lonza and Codexis Sign Agreement for Biocatalysis Process II-39 
DSM Signs Licensing Agreement with Chiral Quest II-39 
Chiral Quest Signs Distribution Agreement with Aldrich Chemical II-39 
BASF and Solvias to Collaborate on Chiral Molecule Development II-39 
Chiral Quest and Avantium Enter into Partnership II-39 

11. Focus on Select Players II-40 
Albemarle Corporation (USA) II-40 
BASF AG (Germany) II-40 
Cambrex Corp. (USA) II-40 
Chiral Quest Inc (US) II-41 
Dalco ChromTech AB (Sweden) II-41 
Daicel Chemical Industries Ltd. (Japan) II-41 
DSM Pharmaceutical Products (Netherlands) II-41 
DowpharmaSM (USA) II-42 
Johnson Matthey PLC (UK) II-42 
Regis Technologies Inc (USA) II-42 
Shasun Chemicals and Drugs Limited (India) II-43 
Solvias (Switzerland) II-43 
Sigma Aldrich Corp (USA) II-43 
Suven Life Sciences Ltd. (USA) II-43 

12. Global Market Perspective II-45 
Table 3: World Recent Past, Current & Future Analysis for 
Chiral Technology Enabling Products by Geographic Region - 
US, Japan, Europe, and Rest of World Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) II-45 

Table 4: World Long-term Projections for Chiral Technology 
Enabling Products by Geographic Region - US, Japan, Europe, 
and Rest of World Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2011 through 2015 
(includes corresponding Graph/Chart) II-46 

Table 5: World 10-Year Perspective for Chiral Technology 
Enabling Products by Geographic Region - Percentage Breakdown 
of Value Sales for US, Japan, Europe, and Rest of World 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) II-47 

Table 6: World Recent Past, Current & Future Analysis for 
Chiral Intermediates by Geographic Region - US, Japan, Europe, 
and Rest of World Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2000 through 2010 
(includes corresponding Graph/Chart) II-48 

Table 7: World Long-term Projections for Chiral Intermediates 
by Geographic Region - US, Japan, Europe, and Rest of World 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-49 

Table 8: World 10-Year Perspective for Chiral Intermediates 
by Geographic Region - Percentage Breakdown of Value Sales 
for US, Japan, Europe, and Rest of World Markets for Years 
2003, 2008 & 2012 (includes corresponding Graph/Chart) II-50 

Table 9: World Recent Past, Current & Future Analysis for 
Chiral Analytical Products by Geographic Region - US, Japan, 
Europe, and Rest of World Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2000 through 
2010 (includes corresponding Graph/Chart) II-51 

Table 10: World Long-term Projections for Chiral Analytical 
Products by Geographic Region - US, Japan, Europe, and Rest 
of World Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-52 
TABLE 11: World 10-Year Perspective for Chiral Analytical 
Products by Geographic Region - Percentage Breakdown of 
Value Sales for US, Japan, Europe, and Rest of World Markets 
for Years 2003, 2008 & 2012 (includes corresponding Graph 
/Chart) II-53 
Table 12: World Recent Past, Current & Future Analysis for 
Other Chiral Technology Enabling Products by Geographic Region 
- US, Japan, Europe, and Rest of World Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) II-54 

Table 13: World Long-term Projections for Other Chiral 
Technology Enabling Products by Geographic Region - US, 
Japan, Europe, and Rest of World Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) II-55 

Table 14: World 10-Year Perspective for Other Chiral 
Technology Enabling Products by Geographic Region - Percentage 
Breakdown of Value Sales for US, Japan, Europe, and Rest of 
World Markets for Years 2003, 2008 & 2012 (includes 
corresponding Graph/Chart) II-56 

Table 15: World Recent Past, Current & Future Analysis for 
Chiral Technology in Pharmaceuticals by Geographic Region - 
US, Japan, Europe, and Rest of World Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) II-57 

Table 16: World Long-term Projections for Chiral Technology 
in Pharmaceuticals by Geographic Region - US, Japan, Europe, 
and Rest of World Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2011 through 2015 
(includes corresponding Graph/Chart) II-58 

Table 17: World 10-Year Perspective for Chiral Technology in 
Pharmaceuticals by Geographic Region - Percentage Breakdown of 
Value Sales for US, Japan, Europe, and Rest of World Markets 
for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) II-59 

Table 18: World Recent Past, Current & Future Analysis for 
Chiral Technology in Agrochemicals by Geographic Region - US, 
Japan, Europe, and Rest of World Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) II-60 

Table 19: World Long-term Projections for Chiral Technology 
in Agrochemicals by Geographic Region - US, Japan, Europe, 
and Rest of World Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2011 through 2015 
(includes corresponding Graph/Chart) II-61 

Table 20: World 10-Year Perspective for Chiral Technology in 
Agrochemicals by Geographic Region - Percentage Breakdown of 
Value Sales for US, Japan, Europe, and Rest of World Markets 
for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) II-62 

III. MARKET 

1. The United States III-1 
A.Market Analysis III-1 
Overview III-1 
Product Introductions/Developments III-1 
Strategic Corporate Developments III-2 
Select Players III-3 
Albemarle Corporation III-3 
Cambrex Corp. III-3 
Chiral Quest Inc III-4 
DowpharmaSM III-4 
Regis Technologies Inc III-4 
Sigma Aldrich Corp III-5 
Suven Life Sciences Ltd. III-5 
B.Market Analytics III-6 
Table 21: US Recent Past, Current & Future Analysis for Chiral 
Technology Enabling Products by Product Segment - 
Intermediates, Analytical, and Other Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-6 

Table 22: US Long-term Projections for Chiral Technology 
Enabling Products by Product Segment - Intermediates, 
Analytical, and Other Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2011 through 
2015 (includes corresponding Graph/Chart) III-6 

TABLE 23: US 10-Year Perspective for Chiral Technology 
Enabling Products by Product Segment - Percentage Breakdown 
of Value Sales for Intermediates, Analytical, and Other 
Markets for Years 2003, 2008 & 2012 (includes 
corresponding Graph/Chart) III-7 

Table 24: US Recent Past, Current & Future Analysis for 
Chiral Technology by End-Use Segment - Pharmaceuticals, and 
Agrochemicals Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-8 

Table 25: US Long-term Projections for Chiral Technology by 
End-Use Segment - Pharmaceuticals, and Agrochemicals Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) III-8 

Table 26: US 10-Year Perspective for Chiral Technology by 
End-Use Segment - Percentage Breakdown of Value Sales for 
Pharmaceuticals, and Agrochemicals Markets for Years 2003, 
2008 & 2012 III-9 

2. Japan III-10 
A.Market Analysis III-10 
Outlook III-10 
Daicel Chemical Industries Ltd - A Major Player III-10 
B.Market Analytics III-11 
Table 27: Japanese Recent Past, Current & Future Analysis for 
Chiral Technology Enabling Products by Product Segment - 
Intermediates, Analytical, and Other Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-11 

Table 28: Japanese Long-term Projections for Chiral Technology 
Enabling Products by Product Segment - Intermediates, 
Analytical, and Other Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2011 through 
2015 (includes corresponding Graph/Chart) III-11 

Table 29: Japanese 10-Year Perspective for Chiral Technology 
Enabling Products by Product Segment - Percentage Breakdown of 
Value Sales for Intermediates, Analytical, and Other Markets 
for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-12 

Table 30: Japanese Recent Past, Current & Future Analysis for 
Chiral Technology by End-Use Segment - Pharmaceuticals, and 
Agrochemicals Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-13 

Table 31: Japanese Long-term Projections for Chiral Technology 
by End-Use Segment - Pharmaceuticals, and Agrochemicals 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) III-13 

Table 32: Japanese 10-Year Perspective for Chiral Technology 
by End-Use Segment - Percentage Breakdown of Value Sales for 
Pharmaceuticals and Agrochemicals Markets for Years 2003, 
2008 & 2012 III-14 

3. Europe III-15 
A.Market Analysis III-15 
Overview III-15 
Product Introductions III-15 
Strategic Corporate Developments III-16 
Select Players III-17 
BASF AG (Germany) III-17 
Dalco ChromTech AB (Sweden) III-18 
DSM Pharmaceutical Products (Netherlands) III-18 
Johnson Matthey PLC (UK) III-18 
Solvias (Switzerland) III-19 
B.Market Analytics III-19 
Table 33: European Recent Past, Current & Future Analysis for 
Chiral Technology Enabling Products by Product Segment - 
Intermediates, Analytical, and Other Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-19 

Table 34: European Long-term Projections for Chiral Technology 
Enabling Products by Product Segment - Intermediates, 
Analytical, and Other Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2011 through 
2015 (includes corresponding Graph/Chart) III-20 

Table 35: European 10-Year Perspective for Chiral Technology 
Enabling Products by Product Segment - Percentage Breakdown of 
Value Sales for Intermediates, Analytical, and Other Markets 
for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-20 

Table 36: European Recent Past, Current & Future Analysis for 
Chiral Technology by End-Use Segment - Pharmaceuticals, and 
Agrochemicals Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-21 

Table 37: European Long-term Projections for Chiral Technology 
by End-Use Segment - Pharmaceuticals, and Agrochemicals 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) III-21 

Table 38: European 10-Year Perspective for Chiral Technology 
by End-Use Segment - Percentage Breakdown of Value Sales for 
Pharmaceuticals, and Agrochemicals Markets for Years 2003, 
2008 & 2012 III-22 

4. Rest of World III-23 
A.Market Analysis III-23 
Outlook III-23 
India III-23 
Chiral Drugs in Indian Market III-23 
China-A Hub for Pharmaceutical Manufacturing III-23 
Strategic Corporate Development III-23 
Shasun Chemicals and Drugs Limited - A Major Indian Player III-23 
B.Market Analytics III-24 
Table 39: Rest of World Recent Past, Current & Future Analysis 
for Chiral Technology Enabling Products by Product Segment - 
Intermediates, Analytical, and Other Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-24 

Table 40: Rest of World Long-term Projections for Chiral 
Technology Enabling Products by Product Segment - 
Intermediates, Analytical, and Other Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-25 

Table 41: Rest of World 10-Year Perspective for Chiral 
Technology Enabling Products by Product Segment - Percentage 
Breakdown of Value Sales for Intermediates, Analytical, and 
Other Markets for Years 2003, 2008 & 2012 (includes 
corresponding Graph/Chart) III-25 

Table 42: Rest of World Recent Past, Current & Future Analysis 
for Chiral Technology by End-Use Segment - Pharmaceuticals, 
and Agrochemicals Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2000 through 2010 
(includes corresponding Graph/Chart) III-26 

Table 43: Rest of World Long-term Projections for Chiral 
Technology by End-Use Segment - Pharmaceuticals, and 
Agrochemicals Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2011 through 2015 
(includes corresponding Graph/Chart) III-26 

Table 44: Rest of World 10-Year Perspective for Chiral 
Technology by End-Use Segment - Percentage Breakdown of Value 
Sales for Pharmaceuticals, and Agrochemicals Markets for Years 
2003, 2008 & 2012 III-27 

IV. COMPETITIVE LANDSCAPE

To order this report:

World Chiral Technology Market

http://www.reportlinker.com/p090558/World-Chiral-Technology-Market.html

More market research reports here!

Contact Information